158 related articles for article (PubMed ID: 3118650)
1. Polyamines in normal and cancer cells.
Luk GD; Casero RA
Adv Enzyme Regul; 1987; 26():91-105. PubMed ID: 3118650
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of polyamine analogs in cancer cells.
Huang Y; Pledgie A; Casero RA; Davidson NE
Anticancer Drugs; 2005 Mar; 16(3):229-41. PubMed ID: 15711175
[TBL] [Abstract][Full Text] [Related]
3. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo.
Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC
Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
6. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
7. Expression of the transforming growth factor-beta gene during growth inhibition following polyamine depletion.
Patel AR; Li J; Bass BL; Wang JY
Am J Physiol; 1998 Aug; 275(2):C590-8. PubMed ID: 9688614
[TBL] [Abstract][Full Text] [Related]
8. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
9. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
[TBL] [Abstract][Full Text] [Related]
10. Tumor attenuation by combined heparan sulfate and polyamine depletion.
Belting M; Borsig L; Fuster MM; Brown JR; Persson L; Fransson LA; Esko JD
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):371-6. PubMed ID: 11752393
[TBL] [Abstract][Full Text] [Related]
11. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
[TBL] [Abstract][Full Text] [Related]
12. The effects of DFMO on polyamine metabolism in the inner ear.
Marks SC; Mattox DE; Casero RA
Hear Res; 1991 Jun; 53(2):230-6. PubMed ID: 1880077
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of immediate-early-gene induction in renal mesangial cells by depletion of intracellular polyamines.
Schulze-Lohoff E; Fees H; Zanner S; Brand K; Sterzel RB
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):647-53. PubMed ID: 8141779
[TBL] [Abstract][Full Text] [Related]
15. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells.
Grossi M; Phanstiel O; Rippe C; Swärd K; Alajbegovic A; Albinsson S; Forte A; Persson L; Hellstrand P; Nilsson BO
J Cell Physiol; 2016 Jun; 231(6):1334-42. PubMed ID: 26529275
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
18. Increased glucose oxidation and contents of insulin and ATP in polyamine-depleted rat insulinoma cells (RINm5F).
Sjöholm A; Welsh N; Hoftiezer V; Bankston PW; Hellerström C
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):533-40. PubMed ID: 1859381
[TBL] [Abstract][Full Text] [Related]
19. alpha-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model.
Takahashi Y; Mai M; Nishioka K
Int J Cancer; 2000 Jan; 85(2):243-7. PubMed ID: 10629084
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and polyamine metabolism in 9L cells treated with (2R,5R)-6-heptyne-2,5-diamine or alpha-difluoromethylornithine.
Milam KM; Deen DF; Marton LJ
Cell Tissue Kinet; 1989 May; 22(3):269-77. PubMed ID: 2509072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
